Excelsior Biopharma Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 1,540.064 million compared to TWD 1,689.124 million a year ago. Operating income was TWD 85.799 million compared to TWD 282.086 million a year ago. Net income was TWD 71.012 million compared to TWD 221.827 million a year ago. Basic earnings per share was TWD 1.52 compared to TWD 4.75 a year ago. Diluted earnings per share was TWD 1.52 compared to TWD 4.71 a year ago.